The president of Thailand's Pharmaceutical Research and Manufacturers Association (PReMA), Teera Chakajnarodom, plans to meet with the country's Public Health Minister, Chaiya Sasomsap, and the latter's Commerce and Foreign Ministries' colleagues, over the shifting policy on compulsory drug licensing (Marketletter March 17). The PReMA chief also told reporters that he endorses the decision of the Health Minister to switch responsibility for price negotiations with drugmakers to the Commerce Ministry.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze